by lythamcorp | Nov 14, 2024 | Reviva Pharma News
– 108 patients have completed 1-year of treatment in 1-year open-label extension (OLE) trial – – Vocal biomarker speech latency data from RECOVER trial reinforce brilaroxazine’s improvement on negative symptoms and other key symptom domains of...
by lythamcorp | Nov 14, 2024 | Healthcare, Precision Optics, Precision Optics News, Technology
Second single-use program to move into production this year highlights new growth opportunity for Precision OpticsGARDNER, Mass., Nov. 14, 2024 — Precision Optics Corporation, Inc. (Nasdaq: POCI) (the “Company”), a leading designer and manufacturer...
by lythamcorp | Nov 14, 2024 | Healthcare, Precision Optics, Precision Optics News, Technology
Conference Call Scheduled for today, November 14, 2024, at 5:00pm ET.GARDNER, Mass., Nov. 14, 2024 — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace...
by lythamcorp | Nov 14, 2024 | Industrials, Jewett Cameron, Jewett Cameron News
NORTH PLAINS, Ore., Nov. 14, 2024 — Jewett-Cameron Trading Company Ltd. (“Jewett-Cameron”) (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, will report its operational and financial results for its fiscal 2024...
by lythamcorp | Nov 14, 2024 | Industrials, S&W Seed Co, SW Seed News
Conference call to be conducted on Tuesday, November 19, 2024, at 11:00 a.m. ET LONGMONT, Colo., Nov. 14, 2024 — S&W Seed Company (Nasdaq: SANW) will report financial results for its first quarter fiscal year 2025, ended September 30, 2024, on Tuesday,...